Bots, editor, reviewer, Administrators
13,941
edits
No edit summary |
No edit summary |
||
Line 534: | Line 534: | ||
"title" : "Andexanet alfa for the reversal of factor Xa inhibitor activity", | "title" : "Andexanet alfa for the reversal of factor Xa inhibitor activity", | ||
"pmid" : "26559317" | "pmid" : "26559317" | ||
}, | |||
{ | |||
"timestamp" : "2018-06-08T20:03:21Z", | |||
"briefDesignDescription" : "Andexanet for reversing Xa inhibitors", | |||
"fulltexturl" : "https://www.nejm.org/doi/full/10.1056/NEJMoa1607887", | |||
"pageid" : 3641, | |||
"pdfurl" : null, | |||
"trainingLevel" : "Resident", | |||
"citation" : "Connolly SJ, <i>et al</i>. \"Andexanet alfa for the reversal of factor Xa inhibitor activity\". <i>The New England Journal of Medicine</i>. 2016. 375(12):1131-1141.", | |||
"subspecialties" : "Hematology", | |||
"expansion" : "Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of FXA Inhibitors", | |||
"statusUsableDate" : "2012-03-01", | |||
"briefResultsDescription" : "Andexanet reverses Xa inhibitors", | |||
"published" : "2016-09-22", | |||
"pageName" : "ANNEXA-4", | |||
"diseases" : "Hemorrhage", | |||
"abbreviation" : "ANNEXA-4", | |||
"title" : "Andexanet alfa for the reversal of factor Xa inhibitor activity", | |||
"pmid" : "27573206" | |||
}, | }, | ||
{ | { |